Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study

Autor: Rougier, P. *, Lepille, D., Bennouna, J., Marre, A., Ducreux, M., Mignot, L., Hua, A., Méry-Mignard, D.
Zdroj: In Annals of Oncology October 2002 13(10):1558-1567
Databáze: ScienceDirect